Back to Search
Start Over
Anti-PD-1 antibody increases NK cell cytotoxicity towards nasopharyngeal carcinoma cells in the context of chemotherapy-induced upregulation of PD-1 and PD-L1
- Source :
- Cancer Immunology, Immunotherapy, Cancer immunology immunotherapy : CII 70(2), 323-336 (2020). doi:10.1007/s00262-020-02681-x
- Publication Year :
- 2020
-
Abstract
- Cancer immunology immunotherapy : CII (2020). doi:10.1007/s00262-020-02681-x<br />Published by Springer, Heidelberg
- Subjects :
- Cancer Research
medicine.medical_treatment
Immunology
Programmed Cell Death 1 Receptor
Mice, Nude
Transfection
03 medical and health sciences
Mice
0302 clinical medicine
PD-L1
Cell Line, Tumor
medicine
Immunology and Allergy
Animals
Humans
Chemotherapy
ddc:610
Cytotoxicity
030304 developmental biology
Cisplatin
0303 health sciences
Nasopharyngeal Carcinoma
Programmed cell death ligand 1
biology
business.industry
Induction chemotherapy
Immunotherapy
medicine.disease
Interferon beta
Gemcitabine
Up-Regulation
Killer Cells, Natural
Nuclear factor kappa b
Oncology
Nasopharyngeal carcinoma
030220 oncology & carcinogenesis
biology.protein
Cancer research
Natural killer cells
Female
Original Article
business
medicine.drug
Subjects
Details
- ISSN :
- 14320851
- Volume :
- 70
- Issue :
- 2
- Database :
- OpenAIRE
- Journal :
- Cancer immunology, immunotherapy : CII
- Accession number :
- edsair.doi.dedup.....2c39405ddacda56866a5164170002494